Astellas Pharma is the famous Corporate Investor, which was founded in 2005. The main department of described Corporate Investor is located in the Tokyo. The fund was located in Asia if to be more exact in Japan.
The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Life Science. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FibroGen, CoMentis, Catalia Health.
The fund was created by Erik Karrer.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Astellas Pharma, startups are often financed by Khosla Ventures, Wellington Partners, Silicon Valley Growth Syndicate. The meaningful sponsors for the fund in investment in the same round are The House Fund, Shibuya Kogyo, Shanda Group. In the next rounds fund is usually obtained by Tony Ling, SMBC Venture Capital, SBI Investment.
The top amount of exits for fund were in 2017. Considering the real fund results, this Corporate Investor is 23 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Astellas Pharma works on 0 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| Adani Capital | Central, Central Region, Singapore |
| Ajayi Solutions | - |
| Bondi Pacific Pty Ltd | Australia, New South Wales, Sydney |
| GMT Communications Partners | England, London, United Kingdom |
| GRO Capital | Copenhagen, Denmark, Hovedstaden |
| Jaszac Investments | - |
| Lisa Dean Moseley Foundation | - |
| Mela Ventures | Bengaluru, India, Karnataka |
| OSS Capital, L.P. | California, San Francisco, United States |
| SevenBridge Financial Group | Harrisburg, Pennsylvania, United States |
| Shanghai Yousu Investment Management | China, Shanghai |
| Shell Energy North America | Houston, Texas, United States |
| SHiP | China, Guangdong, Shenzhen |
| Stratos Ventures | Finland, Helsinki, Southern Finland |
| Sustainable Ocean Alliance | - |
| Tigerlabs | New Jersey, Princeton, United States |
| VectoIQ LLC | New York, New York, United States |
| VOYAGERS Health-Tech Fund | - |
| Zall Group | China, Hubei, Wuhan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Iota Biosciences | $15M | 27 Dec 2018 | Berkeley, California, United States | ||
Heartseed | $7M | 30 Jul 2018 | Chiyoda | ||
Mitobridge | $5M | 04 Oct 2013 | Cambridge, Massachusetts, United States | ||
Telsar Pharma | $14M | 24 Apr 2012 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Iota Biosciences | $15M | 27 Dec 2018 | Berkeley, California, United States | ||
Heartseed | $7M | 30 Jul 2018 | Chiyoda | ||
Mitobridge | $5M | 04 Oct 2013 | Cambridge, Massachusetts, United States | ||
Telsar Pharma | $14M | 24 Apr 2012 | New Jersey, United States |
